NEW YORK, Feb 26 – Pharmacopeia of Princeton, NJ, said Monday it would combine its four life science software units into a single entity, effective June 1.
“We’ve been acquiring different software businesses all related to drug discovery and chemical development, so we’re going to continue doing what we do, which is design and sell software to help our customers discover drugs and develop chemicals, but now we’ll just do it under one name since all the products are basically related,” Sue Rodney, manager of investor relations at Pharmacopeia, told GenomeWeb.